Skip to main content
. Author manuscript; available in PMC: 2010 Apr 29.
Published in final edited form as: J Neurodegener Regen. 2009 Sep 1;2(1):39–44.

Figure 3.

Figure 3

CCL11 mRNA levels in control or axotomized WT (black bars) and presymptomatic mSOD1 (grey bars) mouse facial motor nucleus at 7, 14, and 30 days after facial nerve axotomy. Control CCL11 mRNA levels are displayed as the percent change between the right (axotomized) side and the left (uninjured) control side within each animal. At 7, 14, and 30 days post-axotomy, CCL11 mRNA levels are displayed as the percent change between the right (axotomized) side and the left (uninjured) control side within each animal. Bar heights represent means (±SEM). *Denotes significant differences at p ≤ 0.01.